Medico Remedies (MEDICO) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
1.5B
Gross Profit
426.1M
28.23%
Operating Income
119.7M
7.93%
Net Income
100.9M
6.69%
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
573.3M
Shareholders Equity
624.7M
Debt to Equity
0.92
Cash Flow Metrics
Operating Cash Flow
-3.7M
Free Cash Flow
17.0M
Revenue & Profitability Trend
Medico Remedies Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.4B | 1.4B | 1.2B | 1.2B |
| Cost of Goods Sold | 1.1B | 1.2B | 1.1B | 957.3M | 989.8M |
| Gross Profit | 426.1M | 247.1M | 257.7M | 226.2M | 208.6M |
| Operating Expenses | 213.3M | 74.9M | 123.4M | 123.2M | 117.0M |
| Operating Income | 119.7M | 100.3M | 69.0M | 53.1M | 55.6M |
| Pre-tax Income | 135.0M | 113.3M | 101.0M | 64.8M | 37.0M |
| Income Tax | 34.1M | 30.4M | 28.6M | 16.7M | 11.1M |
| Net Income | 100.9M | 82.9M | 72.4M | 48.1M | 25.9M |
| EPS (Diluted) | - | ₹1.00 | ₹0.87 | ₹0.58 | ₹0.31 |
Income Statement Trend
Medico Remedies Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 966.8M | 737.6M | 645.4M | 575.7M | 577.3M |
| Non-Current Assets | 231.2M | 224.3M | 229.1M | 198.3M | 170.9M |
| Total Assets | 1.2B | 962.0M | 874.5M | 774.0M | 748.2M |
| Liabilities | |||||
| Current Liabilities | 569.6M | 428.1M | 417.7M | 381.4M | 379.3M |
| Non-Current Liabilities | 3.7M | 10.1M | 18.4M | 26.9M | 50.7M |
| Total Liabilities | 573.3M | 438.2M | 436.1M | 408.3M | 430.0M |
| Equity | |||||
| Total Shareholders Equity | 624.7M | 523.7M | 438.4M | 365.7M | 318.2M |
Balance Sheet Composition
Medico Remedies Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 100.9M | 82.9M | 72.4M | 48.1M | 25.9M |
| Operating Cash Flow | -3.7M | -13.7M | 7.9M | 18.0M | -384.7M |
| Investing Activities | |||||
| Capital Expenditures | -31.8M | -24.7M | -65.9M | -29.0M | -169.6M |
| Investing Cash Flow | -32.7M | -25.7M | -66.7M | -29.2M | -172.0M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | - | - | -26.1M | 66.7M | 171.3M |
| Free Cash Flow | 17.0M | 2.0M | 15.7M | -505.0K | -282.7M |
Cash Flow Trend
Medico Remedies Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
40.59
Price to Book
6.62
Price to Sales
2.72
Profitability Ratios
Profit Margin
6.69%
Operating Margin
14.28%
Return on Equity
17.58%
Return on Assets
6.93%
Financial Health
Current Ratio
1.70
Debt to Equity
23.53
Beta
0.18
Per Share Data
EPS (TTM)
₹1.22
Book Value per Share
₹7.48
Revenue per Share
₹18.25
Financial data is updated regularly. All figures are in the company's reporting currency.